𝔖 Bobbio Scriptorium

✦ LIBER ✦

PCN79 Pharmacoeconomic Evaluation of Acute Myeloid Leukemia and MDS Syndromes (Intermediate and High Risk) Treatment With Azacitidine in the Russian Federation

✍ Scribed by A. Kulikov; R. Yagudina; B. Misikova

Book ID: 119312365
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 61 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.2119

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clofarabine : In search of combinations

Clofarabine : In search of combinations for the treatment of patients with high-risk acute myeloid leukemia

✍ Pellegrino Musto; Felicetto Ferrara 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Combining Azacitidine (Vidaza®, Aza) and

Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

High-dose versus intermediate-dose cytos

High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia—preliminary clinical and pharmacological data of a randomized comparison

✍ Hiddemann, Wolfgang; Schleyer, Eberhard; Uhrmeister, Christa; Aul, Carlo H.; Mas 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Clofarabine in combination with a standa

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

✍ Willemze, R.; Suciu, S.; Muus, P.; Halkes, C. J. M.; Meloni, G.; Meert, L.; Karr 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 197 KB

Randomized evaluation of the efficacy of

Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial

✍ David H. Fitchett; Anatoly Langer; Paul W. Armstrong; Mary Tan; Aurora Mendelsoh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB